Dr. Mohamed Farhat, MD

  • Crown Point, IN
  • Medical oncologist
NPI1104082809PAC ID1052465721
Medicare services, 2024
36,827
Medicare patients, 2024
663
Part D claims, 2024
1,175
Publications
13
Hospital affiliations
5
Practice address
1205 S Main St, Crown Point, IN 46307
Practice phone
Call (574) 237-1328
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Michiana Hematology-Oncology P C

Crown Point, Indiana

See all 12 affiliations

Find Dr. Farhat's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mohamed Farhat is a medical oncologist in Crown Point, Indiana

Dr. Farhat practices at Michiana Hematology-Oncology P C in Crown Point, Indiana.

Dr. Farhat's NPI, 1104082809, was assigned on August 1, 2008. Dr. Farhat holds Indiana license 01066282A.

NPI and contact details
Medicare PAC ID
1052465721
NPI enumeration date
August 1, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(574) 237-1328
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mohamed Farhat practices at Michiana Hematology-Oncology P C in Crown Point, Indiana

Dr. Farhat's primary practice is Michiana Hematology-Oncology P C, at 1205 S Main St, Crown Point, IN 46307 in Lake County. The practice phone is (574) 237-1328.

  • Michiana Hematology-Oncology P C
    1205 S Main St, Crown Point, IN 46307 · Lake CountyPhone(574) 237-1328

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mohamed Farhat is affiliated with 9 sites of care and 3 medical groups

Dr. Farhat's primary practice is Michiana Hematology-Oncology P C in Crown Point, Indiana. Dr. Farhat is also affiliated with University of Chicago Medical Center. The medical group on file is Michiana Hematology-Oncology, PC. Dmand AI also links Dr. Farhat to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

See all 12 affiliations for Dr. Farhat

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Mohamed Farhat's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhat practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Michiana Hematology-Oncology P CAvailable with a free account
+8 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Farhat practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mohamed Farhat is one of 72 medical oncologists in Indiana

Medical oncology is Dr. Farhat's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Farhat is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Farhat's licenses on file in 3 states: Indiana, Illinois and Michigan.

Specialties and state licenses

  • Medical oncology, IndianaPrimaryLicense 01066282A · taxonomy 207RX0202X
  • Internal medicine, IllinoisLicense 036-116126 · taxonomy 207R00000X
  • Michigan licenseLicense 4301095492

Medical oncologists near Dr. Farhat

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mohamed Farhat billed Medicare for 36,827 services in 2024

CMS data shows 36,827 Medicare services from Dr. Farhat across 24 procedure codes in 2024, for 663 Medicare patients. Medicare paid $313,746 for them.

Medicare services, 202436,827
Medicare patients663
Paid by Medicare$313,746
Procedure codes24

Dr. Farhat's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 122,7482024: 33,67073%
Office and hospital visits
2023: 2,1482024: 1,9619%
Tests and treatments
2023: 2,2312024: 75566%
Surgery
2023: 152024: 4412840%
Imaging
2023: 302024: 0100%
Other services
2023: 42,4552024: 0100%

Where Dr. Farhat's Medicare services took place, 2024

  • In an office36,693100%
  • In a facility1340%

Dr. Farhat compared with the Indiana median for medical oncologists, 2024

  • Dr. Farhat
  • Indiana median
Medicare services
36,827vs 91440.3 times
Medicare patients
663vs 33697% above
Part D claims
964vs 65447% above

Medians across 72 medical oncologists in Indiana with Dmand AI profiles that report each measure.

Dr. Farhat's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Farhat

Need commercial claims for Dr. Farhat?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Farhat and other medical oncologists in Indiana.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mohamed Farhat treated 663 Medicare patients in 2024, average age 74

CMS counts 663 Medicare patients who saw Dr. Farhat in 2024. The largest group is 65 to 74, with 304 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farhat's median patient age at 70, with 61% women.

Medicare patients, 2024663
Average age74
Average risk score1.68
Also on Medicaid9%

Dr. Farhat's Medicare patients by age, 2024

Dr. Farhat's Medicare patients by sex, 2024

  • Women40561%
  • Men25839%

Chronic conditions among Dr. Farhat's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis48%
  4. Cancer47%
  5. Diabetes32%
  6. Ischemic heart disease32%
  7. Chronic kidney disease29%
  8. Anxiety26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Farhat's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women61%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mohamed Farhat wrote 1,175 Medicare Part D claims in 2024

In 2024, Dr. Farhat wrote 1,175 Medicare Part D claims for 265 patients. 84% of them were for generic drugs. CMS names the drug for 964 of them, across 26 drugs with 11 or more claims each, at $271,623 in total drug cost. In 2023, CMS named 1,532 claims across 38 drugs.

Part D claims, 20241,175
Drugs named by CMS26
Total drug cost$271,623
Part D patients265

Dr. Farhat's Part D claims by kind of drug, 2024

  • Generic984 claims84%
  • Brand-name and other191 claims16%

Dr. Farhat's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Farhat's Part D claims, 2024

  • Opioids10%115 of 1,175 claims
  • Antibiotics3%35 of 1,175 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,5322024: 96437%

Drugs named by CMS: 26 in 2024, 38 in 2023.

See all prescribing by Dr. Farhat

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Mohamed Farhat takes part in Medicare

Dr. Farhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Farhat by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mohamed Farhat has 13 publications on record

Dmand AI links 13 papers to Dr. Farhat, published from 2011 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Intracranial Aneurysm, Stents and Cerebrovascular Circulation. Dr. Farhat has published most often in Magn Reson Med. Dr. Farhat's most frequent co-author is John Patrick Furia, MD.

Papers13
Years published2011 to 2023

Dr. Farhat's papers by year, 2011 to 2023

Topics Dr. Farhat writes about most

  • Intracranial Aneurysm
  • Stents
  • Cerebrovascular Circulation
  • Hemodynamics
  • Blood Flow Velocity
  • Rheology
  • Algorithms
  • Artifacts

Dr. Farhat's most frequent co-authors

Recent publications by Dr. Farhat

See all 13 publications and co-authors

See who Dr. Farhat researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Farhat works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mohamed Farhat received $25,823 in industry payments from 2016 to 2025

CMS Open Payments shows 112 general payments to Dr. Farhat from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Alexion Pharmaceuticals, Inc. paid the most, $13,659.

General payments to Dr. Farhat by program year, 2016 to 2025

General payments to Dr. Farhat by kind, 2016 to 2025

$25.8Kin total
  • Consulting fees$12,46048%
  • Honoraria$4,50017%
  • Travel and lodging$3,07812%
  • Food and beverage$3,04712%
  • Other$2,73711%

Companies that paid Dr. Farhat the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Farhat

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mohamed Farhat is board certified in hematology

  1. Board certified in hematologyAmerican Board of Internal Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Mohamed Farhat's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mohamed Farhat

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mohamed Farhat's NPI number?

Dr. Mohamed Farhat's NPI number is 1104082809. It was assigned on August 1, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Mohamed Farhat?

Dr. Mohamed Farhat is a medical oncologist in Crown Point, Indiana. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Mohamed Farhat practice?

Dr. Farhat practices at 1205 S Main St, Crown Point, IN 46307. Dr. Farhat's primary practice is Michiana Hematology-Oncology P C in Crown Point, Indiana. Dmand AI also links Dr. Farhat to 4 hospitals, 3 group practices and clinics and 2 medical groups.

What is Dr. Mohamed Farhat's office phone number?

The practice phone on file for Dr. Farhat is (574) 237-1328.

What is Dr. Mohamed Farhat's medical license number?

Dr. Farhat holds Indiana license 01066282A, one of the licenses on file in 3 states.

Which states has Dr. Mohamed Farhat been licensed in?

Dmand AI has state licenses on file for Dr. Farhat in Indiana, Illinois and Michigan.

Which hospitals is Dr. Mohamed Farhat affiliated with?

Dr. Farhat is affiliated with University of Chicago Medical Center. Dmand AI links Dr. Farhat to 4 more hospitals.

What medical group is Dr. Mohamed Farhat part of?

Dr. Farhat is linked to Michiana Hematology-Oncology, PC. Dmand AI links Dr. Farhat to 2 more medical groups.

Does Dr. Mohamed Farhat accept Medicare?

Yes. CMS data shows Dr. Farhat billed Medicare for 36,827 services in 2024, and Dr. Farhat accepts Medicare assignment.

How many Medicare patients does Dr. Mohamed Farhat see?

CMS counts 663 Medicare patients who saw Dr. Farhat in 2024, with an average age of 74.

Show 7 more questionsShow fewer questions

Is Dr. Mohamed Farhat board certified?

Yes. Dr. Farhat is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Mohamed Farhat bill to Medicare?

In 2024, Dr. Farhat's most billed Medicare services were injected or infused drug (J1756), injected or infused drug (J0897) and office visit, established patient (99215).

What drugs does Dr. Mohamed Farhat prescribe most?

In 2024 Medicare Part D data, Dr. Farhat's most prescribed drugs by claims were Pantoprazole Sodium, Anastrozole and Prochlorperazine Maleate.

Has Dr. Mohamed Farhat received payments from drug or device companies?

CMS Open Payments shows $25,823 in general payments to Dr. Farhat from 34 companies from 2016 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.

How long has Dr. Mohamed Farhat been practicing?

Dr. Farhat graduated from medical school in 2003, 23 years ago.

Does Dr. Mohamed Farhat do research?

Dmand AI links 13 publications to Dr. Farhat, published from 2011 to 2023.

Who does Dr. Mohamed Farhat publish with?

Dr. Farhat's most frequent co-authors are John Patrick Furia, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Indiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)